通过严重的精神表现揭露威尔逊病:一个病例报告
Filipe Dias1, Ana Santos E Silva1, Margarida Santos1
1Internal Medicine, Unidade Local de Saúde do Litoral Alentejano, Santiago do Cacém, PRT.
Cureus
|February 23, 2026
概括
威尔逊病是一种遗传性铜代谢障碍,最初可以呈现为严重的精神症状. 早期诊断和治疗,即使是非典型的表现,对于患者的改善至关重要.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 内部医学 内部医学
背景情况:
- 威尔逊病是一种遗传性疾病,影响铜恒温.
- 临床表现非常可变,有时模仿初级精神疾病.
- 延迟诊断可能会导致严重的发病率.
研究的目的:
- 突出考虑非典型精神病呈现的年轻成年人威尔逊病的重要性.
- 为了说明复杂病例的诊断过程和成功治疗.
主要方法:
- 一个38岁的妇女的病例报告,急性行为变化.
- 神经学和眼科检查,实验室研究 (血清铜,脑部核磁共振),以及分子分析 (ATP7B变种).
- 用青胺和精神病学稳定治疗.
主要成果:
- 患者表现出公开的无抑制,运动激动,关节障碍,以及额外的pyramidal标志.
- 眼科检查显示了凯瑟-弗莱舍尔环.
- 实验室发现包括血小板缺血,氨基转移酶的升高,低血红胺和低血清铜.
- 大脑MRI显示了基底和thalamic超强度.
- 分子分析证实了一种致病性ATP7B变体.
结论:
- 急性精神病和精神病综合征可能是威尔逊病的主要表现.
- 在年轻人中诊断威尔逊病时,需要高度的怀疑指数,这些年轻人具有非典型的精神症状,脱节症,额外金字塔症状和眼科异常.
- 早期诊断和治疗导致逐渐的临床改善.
相关概念视频
01:24Mania and Antimanic Drugs: Overview
702
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
702
01:26Psychosis: Goals of Pharmacotherapy
636
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
636
01:28Drug Therapy
320
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
320
01:28Psychosis and Antipsychotic Drugs: Overview
1.0K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.0K
01:26Positive Symptoms Schizophrenia: Hallucinations and Delusions
754
Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
Hallucinations
Hallucinations in...
754
01:30Dissociative Identity Disorder
1.2K
Dissociative Identity Disorder (DID), previously termed multiple personality disorder, is a complex psychological condition characterized by the presence of two or more distinct identities or personality states. Each identity exhibits unique patterns of behavior, voice, and mannerisms and may possess separate memories and emotional responses. The alternating control between identities can result in memory gaps and challenges in recalling daily activities, often exacerbating the individual's...
1.2K